Ascendis Pharma A/S American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ASND Company Description
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
ASND Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ASND Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ASND by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ASND's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ASND in WallStreetBets Daily Discussion
ASND News
Recent insights relating to ASND
CNBC Recommendations
Recent picks made for ASND stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ASND
Corporate Flights
Flights by private jets registered to ASND
Our Analysis